BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1324317)

  • 41. Synthesis and biological evaluation of N-aryl-4-aryl-1,3-thiazole-2-amine derivatives as direct 5-lipoxygenase inhibitors.
    Suh J; Yum EK; Cheon HG; Cho YS
    Chem Biol Drug Des; 2012 Jul; 80(1):89-98. PubMed ID: 22404847
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pseudoperoxidase activity of 5-lipoxygenase stimulated by potent benzofuranol and N-hydroxyurea inhibitors of the lipoxygenase reaction.
    Riendeau D; Falgueyret JP; Guay J; Ueda N; Yamamoto S
    Biochem J; 1991 Feb; 274 ( Pt 1)(Pt 1):287-92. PubMed ID: 2001245
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel imidazole compounds as a new series of potent, orally active inhibitors of 5-lipoxygenase.
    Mano T; Stevens RW; Ando K; Nakao K; Okumura Y; Sakakibara M; Okumura T; Tamura T; Miyamoto K
    Bioorg Med Chem; 2003 Sep; 11(18):3879-87. PubMed ID: 12927848
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Methoxyalkyl thiazoles: a novel series of potent, orally active and enantioselective inhibitors of 5-lipoxygenase.
    McMillan RM; Bird TG; Crawley GC; Edwards MP; Girodeau JM; Kingston JF; Foster SJ
    Agents Actions; 1991 Sep; 34(1-2):110-2. PubMed ID: 1793013
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regio- and stereoselective ring openings of 3-Aza-2-oxabicyclo[2.2.1]hept-5-ene systems with copper catalyst-modified grignard reagents: application to the synthesis of an inhibitor of 5-lipoxygenase.
    Surman MD; Mulvihill MJ; Miller MJ
    J Org Chem; 2002 Jun; 67(12):4115-21. PubMed ID: 12054945
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A class of 5-benzylidene-2-phenylthiazolinones with high potency as direct 5-lipoxygenase inhibitors.
    Hofmann B; Barzen S; Rödl CB; Kiehl A; Borig J; Zivković A; Stark H; Schneider G; Steinhilber D
    J Med Chem; 2011 Mar; 54(6):1943-7. PubMed ID: 21341744
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A rat air pouch model for evaluating the efficacy and selectivity of 5-lipoxygenase inhibitors.
    Zweifel BS; Hardy MM; Anderson GD; Dufield DR; Pufahl RA; Masferrer JL
    Eur J Pharmacol; 2008 Apr; 584(1):166-74. PubMed ID: 18295198
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase.
    McMillan RM; Spruce KE; Crawley GC; Walker ER; Foster SJ
    Br J Pharmacol; 1992 Dec; 107(4):1042-7. PubMed ID: 1334748
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of a novel series of selective inhibitors of arachidonate 5-lipoxygenase on anaphylactic and inflammatory responses.
    Bhattacherjee P; Boughton-Smith NK; Follenfant RL; Garland LG; Higgs GA; Hodson HF; Islip PJ; Jackson WP; Moncada S; Payne AN
    Ann N Y Acad Sci; 1988; 524():307-20. PubMed ID: 2837965
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 5-Lipoxygenase inhibition by N-hydroxycarbamates in dual-function compounds.
    Lewis TA; Bayless L; DiPesa AJ; Eckman JB; Gillard M; Libertine L; Scannell RT; Wypij DM; Young MA
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1083-5. PubMed ID: 15686917
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and 5-lipoxygenase inhibitory activities of some novel 2-substituted 5-benzofuran hydroxamic acids.
    Ohemeng KA; Appollina MA; Nguyen VN; Schwender CF; Singer M; Steber M; Ansell J; Argentieri D; Hageman W
    J Med Chem; 1994 Oct; 37(21):3663-7. PubMed ID: 7932593
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New Hydroxycinnamic Acid Esters as Novel 5-Lipoxygenase Inhibitors That Affect Leukotriene Biosynthesis.
    Boudreau LH; Lassalle-Claux G; Cormier M; Blanchard S; Doucet MS; Surette ME; Touaibia M
    Mediators Inflamm; 2017; 2017():6904634. PubMed ID: 28680195
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The suppression of 5-lipoxygenation of arachidonic acid in human polymorphonuclear leucocytes by the 15-lipoxygenase product (15S)-hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoic acid: structure-activity relationship and mechanism of action.
    Petrich K; Ludwig P; Kühn H; Schewe T
    Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):911-6. PubMed ID: 8615788
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization and pharmacological modulation of antigen-induced peritonitis in actively sensitized mice.
    Zuany-Amorim C; Leduc D; Vargaftig BB; Pretolani M
    Br J Pharmacol; 1993 Oct; 110(2):917-24. PubMed ID: 7694762
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aminothiazole-featured pirinixic acid derivatives as dual 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 inhibitors with improved potency and efficiency in vivo.
    Hanke T; Dehm F; Liening S; Popella SD; Maczewsky J; Pillong M; Kunze J; Weinigel C; Barz D; Kaiser A; Wurglics M; Lämmerhofer M; Schneider G; Sautebin L; Schubert-Zsilavecz M; Werz O
    J Med Chem; 2013 Nov; 56(22):9031-44. PubMed ID: 24171493
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of indomethacin on arachidonic acid metabolism in human leukocytes stimulated ex vivo.
    Docherty JC; Wilson TW
    Clin Pharmacol Ther; 1991 Mar; 49(3):294-9. PubMed ID: 1848800
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of ionophore-stimulated leukotriene B4 production in human leucocytes by monohydroxy fatty acids.
    Camp RD; Fincham NJ
    Br J Pharmacol; 1985 Aug; 85(4):837-41. PubMed ID: 2994785
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antioxidant and anti-inflammatory activity of aryl-acetic and hydroxamic acids as novel lipoxygenase inhibitors.
    Pontiki E; Hadjipavlou-Litina D
    Med Chem; 2006 May; 2(3):251-64. PubMed ID: 16948471
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity.
    Shrivastava SK; Srivastava P; Bandresh R; Tripathi PN; Tripathi A
    Bioorg Med Chem; 2017 Aug; 25(16):4424-4432. PubMed ID: 28669741
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and structure-activity relationships of a novel class of 5-lipoxygenase inhibitors. 2-(Phenylmethyl)-4-hydroxy-3,5-dialkylbenzofurans: the development of L-656,224.
    Lau CK; Bélanger PC; Scheigetz J; Dufresne C; Williams HW; Maycock AL; Guindon Y; Bach T; Dallob AL; Denis D
    J Med Chem; 1989 Jun; 32(6):1190-7. PubMed ID: 2542553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.